Wararka
-
Cudurka wadnaha wuxuu u baahan yahay daawo cusub - Vericiguat
Wadna xanuunka oo leh jajabka jebinta la dhimay (HFrEF) waa nooca ugu weyn ee wadne-gabka, iyo Daraasada Shiinaha HF waxay muujisay in 42% wadne-gabowga Shiinaha ay yihiin HFrEF, inkastoo dhowr nooc oo daawaynta caadiga ah ay diyaar u yihiin HFrEF ayna hoos u dhigeen khatarta ee...Sii akhri -
Daawada la beegsaday ee daaweynta myelofibrosis: Ruxolitinib
Myelofibrosis (MF) waxaa loo yaqaan myelofibrosis. Sidoo kale waa cudur aad dhif u ah. Sababta keentayna lama garanayo. Calaamadaha caafimaad ee caadiga ah waa unugga dhiigga cas ee dhallinta iyo dhallinta granulocytic anemia oo leh tiro badan oo jeexjeexa unugyada dhiigga casSii akhri -
Waa inaad ogaataa ugu yaraan 3-daan qodob oo ku saabsan rivaroxaban
Sida xinjirowga lidka ku ah afka cusub, rivaroxaban ayaa si weyn loogu isticmaalay ka-hortagga iyo daaweynta cudurka xinjirowga dhiigga xididdada dhiigga iyo ka-hortagga istaroogga ee fibrillada aan valvular ahayn. Si aad si macquul ah ugu isticmaasho rivaroxaban, waa inaad ogaataa ugu yaraan 3-dan qodob....Sii akhri -
Dawaynta Changzhou waxay heshay oggolaansho si ay u soo saarto Kaabsoosha Lenalidomide
Changzhou Pharmaceutical Factory Ltd., oo hoos timaada Shanghai Pharmaceutical Holdings, helay Shahaadada Diiwaangelinta Drug (Certificate No. 2021S01077, 2021S01078, 2021S01078, 2021S01079) ay soo saartay Maamulka Dawooyinka Gobolka ee LenaliSdompeSii akhri -
Waa maxay taxaddarrada loogu talagalay kiniinnada rivaroxaban?
Rivaroxaban, sida xinjirowga lidka ku ah afka cusub, ayaa si weyn loogu isticmaalay ka hortagga iyo daaweynta cudurrada xididdada xididdada dhiigga. Maxaan u baahanahay inaan fiiro gaar ah u yeesho markaan qaadanayo rivaroxaban? Si ka duwan warfarin, rivaroxaban uma baahna la socodka xinjirowga dhiigga ee muujinaya ...Sii akhri -
2021 FDA Ogolaanshaha Dawooyinka Cusub 1Q-3Q
Hal-abuurnimadu waxay horseedaa horumarka. Marka ay timaaddo hal-abuurnimada soo saarista dawooyinka cusub iyo alaabada bayoolojiga lagu daweeyo, Xarunta Qiimaynta iyo Cilmi-baadhista ee FDA (CDER) waxay taageertaa warshadaha dawooyinka tallaabo kasta oo hawsha. Iyadoo la fahmi karo...Sii akhri -
Horumarkii ugu dambeeyay ee Sugammadex Sodium ee xilliga hurdada suuxinta
Sugammadex Sodium waa iska caabin cusub oo ah muruqa nasiyeyaasha aan-depolarizing ee xulashada (myorelaxants), kaas oo markii ugu horreysay laga soo sheegay bini'aadamka 2005 tan iyo markaas si caafimaad ahaan loogu isticmaalay Yurub, Mareykanka iyo Japan. Marka la barbar dhigo daawooyinka dhaqameed ee anticholinesterase...Sii akhri -
Burooyinkee thalidomide waxtar u leh daaweynta!
Thalidomide waxay wax ku ool u tahay daaweynta burooyinkan! 1. Taas oo burooyinka adag loo isticmaali karo thalidomide. 1.1. kansarka sanbabada. 1.2. Kansarka qanjirka 'prostate'. 1.3. Kansarka malawadka noodal. 1.4. kansarka hepatocellular. 1.5. Kansarka caloosha. ...Sii akhri -
Tofacitinib Citrate
Tofacitinib citrate waa dawo dhakhtar soo qoray (magaca ganacsiga Xeljanz) oo asal ahaan ay samaysay Pfizer fasalka ka hortagga Janus kinase (JAK). Waxay si xushmad leh u joojin kartaa JAK kinase, waxay xannibi kartaa dariiqyada JAK/STAT, waxayna joojinaysaa gudbinta calaamadaha unugga iyo muujinta hidda-wadaha la xidhiidha iyo firfircoonida...Sii akhri -
Apixaban iyo Rivaroxaban
Sanadihii la soo dhaafay, iibka apixaban ayaa si xawli ah u koray, iyo suuqa caalamiga ah ayaa mar hore dhaafay rivaroxaban. Sababtoo ah Eliquis (apixaban) ayaa faa'iido u leh warfarin si looga hortago istaroogga iyo dhiig-baxa, Xarelto (Rivaroxaban) kaliya waxay muujisay hoos-u-dhac la'aan. Intaa waxaa dheer, Apixaban ma...Sii akhri -
Bandhiga Guangzhou API ee 2021
Bandhigga 86-aad ee China International Pharmaceutical Pharmaceutical Materials/ Dhexdhexaadiyaha / Baakadaha / Qalabka Carwada (API China oo gaaban) Qabanqaabiyaha: Reed Sinopharm Exhibition Co., Ltd. Waqtiga bandhigga: Meey 26-28, 2021 Goobta: Shiinaha Soo Dejinta iyo Dhoofinta Carwada Complex (Guangzhou) Miisaanka bandhigga: 60,000 mitir oo laba jibbaaran Ex...Sii akhri -
Obeticolic acid
Bishii Juun 29, Intercept Pharmaceuticals waxay ku dhawaaqday inay ka heshay codsi cusub oo cusub FDA ee ku saabsan FXR agonist obeticholic acid (OCA) ee fibrosis ee ay sababtay warqad jawaab celin ah oo aan khamriga ahayn steatohepatitis (NASH) (CRL). FDA waxay ku sheegtay CRL taas oo ku saleysan xogta ...Sii akhri